Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 333 followers
Latest posts
Last updated about 2 hours ago
SPOR and XEVMPD status update webinar - Q3 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 July 2026, 10:00 (CEST) to 8 July 2026, 12:30 (CEST)
about 2 hours ago
SPOR and XEVMPD status update webinar - Q3 2026, Online, European Medicines...
Mandatory use of ISO/ICH E2B(R3) Individual Case Safety Reporting in the EU: Hands-on training course using the EudraVigilance system, Bucharest, Romania, from 26 October 2026 to 28 October 2026
about 2 hours ago
Mandatory use of ISO/ICH E2B(R3) Individual Case Safety Reporting in the EU...
Qualification of novel methodologies for medicinal product development: guidance to applicants
about 3 hours ago
Qualification of novel methodologies for medicinal product development: guidance to applicants
Qualification of novel methodologies for medicine development
about 3 hours ago
Qualification of novel methodologies for medicine development
Human medicines European public assessment report (EPAR): Calquence, acalabrutinib, Date of authorisation: 05/11/2020, Revision: 12, Status: Authorised
about 19 hours ago
Human medicines European public assessment report (EPAR): Calquence, acalabrutinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Altuvoct, efanesoctocog alfa, Date of authorisation: 17/06/2024, Revision: 3, Status: Authorised
about 19 hours ago
Human medicines European public assessment report (EPAR): Altuvoct, efanesoctocog alfa, Date of...
Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 53, Status: Authorised
about 19 hours ago
Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation...
Agenda of the PRAC meeting 6-9 July 2026
about 19 hours ago
Agenda of the PRAC meeting 6-9 July 2026
Agenda of the HMPC meeting 6-8 July 2026
about 20 hours ago
Agenda of the HMPC meeting 6-8 July 2026
Human medicines European public assessment report (EPAR): Enhertu, trastuzumab deruxtecan, Date of authorisation: 18/01/2021, Revision: 20, Status: Authorised
about 20 hours ago
Human medicines European public assessment report (EPAR): Enhertu, trastuzumab deruxtecan, Date of...
Start of procedure: Extension of marketing authorisation (22 May 2026 - 25 June 2026)
about 22 hours ago
Start of procedure: Extension of marketing authorisation (22 May 2026 - 25...
Start of procedure: Type II Variation - Extension of indication under evaluation by the CHMP (22 May 2026 - 25 June 2026)
about 21 hours ago
Start of procedure: Type II Variation - Extension of indication under evaluation...